find our conclusions on the association between the -675 4G/5G PAI-1 polymorphism and obesity, recently published [1] , to be overstated. This statement is based on their study showing no difference in genotype frequency between lean, overweight or obese subjects [2] . However, several questions arise as to interpreting their results. Firstly, the genotype distribution differed from the Hardy-Weinberg equilibrium, which makes the genotyping doubtful. Secondly, a family-based cohort is suitable for linkage, but not association, studies. Finally, given these shortcomings it should be noted that in the Freeman and Mansfield study, the 4G/4G genotype was almost twice as common as the 5G/5G genotype in the overweight and obese groups but there was no difference in the lean group. This is similar to our study [1] , where a higher frequency of 4G/4G and a lower frequency of 5G/5G in obese as compared to lean subjects were observed. Thus, the difference in results between the two studies resides in the p value, which was statistically significant in our study. We believe that our study is more suitable for interpretation, since it was carried out on non-related case-control subjects. Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol
